Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. حسب Hao Deng (409186)

"…As CWP progressed, the CC and CA genotypes of <i>ERCC1</i> rs3212986 decreased and increased significantly, respectively. …"

Seven forecast scenarios. حسب Ryan P. Thombs (9138968)

"…We estimate error correction models, which we ensure are free from residual autocorrelation and structural breaks. We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …"

Forecast for each scenario, 2023-2032. حسب Ryan P. Thombs (9138968)

"…We estimate error correction models, which we ensure are free from residual autocorrelation and structural breaks. We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …"

Anxiolytic (N05B) prescribing changes from 2014 to 2022. حسب Dainty Ei (22265317)

Antidepressant (N06A) prescribing changes from 2014 to 2022. حسب Dainty Ei (22265317)

Changes in the respiration rates of seeds stored under different conditions. حسب Junming Zhang (5446787)

DALYs and ASDR of thyroid cancer in 2021, and their average annual percentage changes from 1990 to 2021. حسب Mengjuan Ding (21560393)

DALYs and ASDR of larynx cancer in 2021, and their average annual percentage changes from 1990 to 2021. حسب Mengjuan Ding (21560393)

DALYs and ASDR of nasopharynx cancer in 2021, and their average annual percentage changes from 1990 to 2021. حسب Mengjuan Ding (21560393)

Changes in inflammatory cytokine levels compared with baseline values in all patients over time. حسب Jia Song (495396)

Distribution of different ingredients at the same IDDSI level (Percentage and frequency) and statistical significance analysis (Chi-square test)^b'*'. حسب Muxi Chen (9294270)

الموضوعات:

Changes in sRAGE levels in BALF after 120 consecutive days of CS exposure. حسب Yue He (385239)

الموضوعات:

Data. حسب Su Hwan Park (15158181)

"…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …"

Control (Ctrl) STZ mice show changes in glomerular morphology. حسب Andrey V. Cybulsky (4007012)

Baseline characteristics of patients. حسب Su Hwan Park (15158181)

"…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …"

Changes in bacterial concentration and monomeric urease activity over time. حسب Xiaoyan Ding (291429)

HFD changes lysosomal activity. حسب Tong Yue (6033305)

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Changes in continuous sleep measures from pre (t1) to post (t2) intervention. حسب Anton Kurapov (11346019)